AtriCure Announces First Patient Enrollment in the DEEP IDE Trial Restart

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. COST
2. AKAM
3. ZS
4. PRME
5. SPY
6. BP
7. CLOV
8. META
9. CNP
10. CRL

Go back to AtriCure Announces First Patient Enrollment in the DEEP IDE Trial Restart
AtriCure, Inc. (NASDAQ: ATRC) Delayed: 60.77 --0 (-0%)
Previous Close $60.77    52 Week High $23.24 
Open $60.77    52 Week Low $13.44 
Day High $60.77    P/E N/A 
Day Low $60.77    EPS $-0.45 
Volume 33